Suchergebnisse - "Park, Y H"

PubPharm (911)

1

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer : Results From the Randomized, Phase II acelERA Breast Cancer Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Martín, M. | Lim, E. | Chavez-MacGregor, M. | +119

2

Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC : exploratory analysis from KEYNOTE-522

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Pusztai, L. | Denkert, C. | O'Shaughnessy, J. | +16

3

Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer : updated survival results from a phase II trial (DESTINY-Breast01)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Saura, C. | Modi, S. | Krop, I. | +11

4

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer

enthalten in: ESMO open | 2023

von Im, S. | Gennari, A. | Park, Y. | +28

5

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Geyer, C. | Garber, J. | Gelber, R. | +174

6

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer : original article

enthalten in: Annals of oncology | 28 November 2022

von Geyer, C. | Garber, J. | Gelber, R. | +73

7

Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients : pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11)

enthalten in: ESMO open | 2021

von Cho, E. | Kim, J. | Im, S. | +11

8

Simplified technique of in-office secondary tracheoesophageal puncture with immediate voice prosthesis placement under transnasal esophagoscope guidance

enthalten in: European annals of otorhinolaryngology, head and neck diseases | 2021

von Park, S. | Park, Y.

9

Midkine Promotes Odontoblast-like Differentiation and Tertiary Dentin Formation

enthalten in: Journal of dental research | 2020

von Park, Y. | Lee, Y. | Seo, Y. | +4

10

Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer : results from the phase 1b open-label, multicohort KEYNOTE-173 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Schmid, P. | Salgado, R. | Park, Y. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[92]